Our Opinion

Telomir Pharmaceuticals Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Supporting Evidence:

The company stated in the following press release that they use animals for product testing.

“Working with Argenta, a leading worldwide animal health research company, this study has the potential to demonstrate both the efficacy of Telomir-1 as well as a benign safety profile. We believe that Telomir-1 will offer an attractive treatment for this indication. Just as important, we believe that the results of this trial could be used to enable our submission of an Investigation New Drug Application to the FDA to study the potential effect of Telomir-1 on osteoarthritis in humans.” Read the following article

Company Description

Telomir Pharmaceuticals, Inc. is a pre-clinical-stage pharmaceutical company. The Company focuses on the development and commercialization of telomir 1, a novel treatment that drive the concentration and accumulation of iron and copper in the serum that affects diseases like hemochromatosis and cancer. Telomir Pharmaceuticals serves customers in the United States.

Company Website: https://telomirpharma.com